Viriom Wins Grant Award To Establish Affiliate In Mainland China

Viriom Inc. (San Diego, CA), has won a grant award in the city of Shaoxing, Zhejiang province, to establish its affiliate in Mainland China. Viriom opened a representative office in Beijing in 2017 and is establishing an affiliate in Hong Kong as part of its five-year plan of drug development and technology transfer to attend to markets, including Greater China, Thailand and Indonesia, where over 5 million people live with an HIV infection.

Viriom Announces NIH/NIAID And Division Of AIDS Collaboration With The Long-Acting/Extended Release Antiviral Resource Program

SAN DIEGO, September 3, 2019 -- Viriom Inc., a clinical stage antiviral company focused on HIV and viral hepatitis (San Diego, CA), is developing long-acting versions of its once daily NNRTI inhibitor, elsulfavirine (Elpida®).  Phase I studies are ongoing, and will now be supplemented by an NIH/NIAID and Division of AIDS collaboration with the Long-Acting/Extended Release Antiviral Resource Program (LEAP).